As companies brace for the impact of last year’s political shocks and looming elections this year, global appetite for mega-mergers may slow amid the prospect of increased protectionism.
The biggest transactions mostly involved buyers and sellers from different countries: Bayer AG’s acquisition of Monsanto Co in the US, China National Chemical Corp’s bid for Syngenta AG and Softbank Group Corp’s purchase of ARM Holdings PLC. Cross-border deals accounted for more than half of acquisitions larger than US$25 billion announced this year, according to data compiled by Bloomberg. They also made up nearly half of the US$3 trillion in total announced deals, the data show.
However, the sources of international mergers and acquisitions are becoming more inward looking and protective, and it is still unclear how political changes will affect businesses. Chinese firms are facing regulatory scrutiny abroad, with growing opposition in the US and Europe, and restrictions on megadeals at home.
In the West, the US elected Donald Trump as its next president — a decision with potential implications for US companies’ tax bills and the reception that bidders, especially Chinese, could get when they target assets in the country. In the UK, which voted to leave the EU, British Prime Minister Theresa May has said the country needs a “proper industrial strategy” that could be used to defend strategic industries and companies like drugmaker AstraZeneca PLC.
This year, Europe will also see elections in the Netherlands, France and Germany that could unseat incumbent leaders and strengthen populist, nationalist movements across the continent. These votes could have ramifications for the EU and euro zone, causing more instability and volatility in the currency bloc.
Here’s what is on the minds of dealmakers as they head into 2017.
1. REGULATION
The largest acquisitions already saw a decline last year. There were 13 deals above US$25 billion announced in 2016, slightly below a year earlier, according to data compiled by Bloomberg. The value of total transactions announced is down about 18 percent from last year.
“Lack of confidence is never good for dealmaking,” said Hernan Cristerna, global co-head of mergers and acquisitions at JPMorgan Chase & Co in London. “If CEOs are trying to gauge the benefits of a big deal and don’t know how the regulatory environment will play out, some may be hesitant to push the button.”
More than US$580 billion in deals were terminated last year, according to the data, some of which can be attributed to a stricter regulatory landscape. The largest failed deal was Pfizer Inc’s US$160 billion attempt to take over rival drug maker Allergan PLC. That was quashed when US regulators proposed new rules to limit so-called tax inversion deals, in which a company gets an address in a more favorable tax regime as part of an acquisition.
The US also blocked deals that it saw as a threat to its national interests, including Chinese-backed Grand Chip Investment GmbH’s plan to buy German chipmaker Aixtron SE, which supplies US defense companies.
The outcome of the US elections and Brexit will result in more protectionism in both countries, said Ying Zhang, associate dean for China at the Rotterdam School of Management at Erasmus University.
There could be “huge resistance” to foreign acquirers as a consequence, she said.
2. ASIA
China, whose companies spent more than US$200 billion on overseas deals last year, more than double last year’s record, is planning curbs on its companies’ foreign acquisitions that will last until September, people with knowledge of the matter said last month. That includes barring most investments of US$10 billion or more.
“The impact of capital-control rules introduced in China has to be assessed, as Chinese companies were among the most active drivers of M&A in the last few years,” said Thomas Piquemal, global head of mergers and acquisitions at Deutsche Bank AG in London.
Japan, which could fill the gap left by Chinese firms’ clipped merger ambitions, represents “the greatest cross-border opportunity,” JPMorgan’s Cristerna said. A shrinking population and stagnant economy at home have pushed businesses in the country to look for growth abroad, he said.
Japanese companies agreed to spend more than US$84 billion acquiring foreign assets last year, up 23 percent from 2015. Softbank’s US$32 billion purchase of ARM Holdings in the UK was the largest of those deals, while brewer Asahi Group Holdings Ltd was one of the most acquisitive, snapping up European assets sold off as part of Anheuser-Busch InBev SA’s merger with SABMiller PLC.
3. PRESIDENT TRUMP
As Trump prepares to take office in 2017, several of his proposals could have sweeping implications for companies that want to do business and deals in the US.
He has called for tax breaks that could lead to the repatriation of US companies’ funds held overseas and lower tax bills. That could free up billions of dollars for mergers and acquisitions in the country, as well as dividends and share buybacks.
“This would free up cash for M&A and fuel a wave of deal activity,” LionTree Advisors chief executive officer Aryeh Bourkoff said in a year-end letter to staff. “Repatriation could be of particular benefit to Apple, Microsoft, Alphabet, Cisco and Oracle, which are holding a combined estimated US$500 billion in cash overseas.”
Trump’s hard line on China could also lead to increased scrutiny of investments from the country into the US. He has nominated former Goldman Sachs Group Inc partner Steven Mnuchin as Treasury secretary, a post that would make him chair of the Committee on Foreign Investment in the US, which has the power to review foreign takeovers of US companies and, if its mandate is broadened, could be used as a tool raise barriers if it opens a path to reject Chinese investments.
Trump also picked Peter Navarro, a University of California at Irvine economics professor and a critic of China’s trade practices, to lead the newly formed White House National Trade Council.
OPTIMISM
Still, some upheaval has created opportunities for buyers. Foreign acquirers spent more on European assets last year than they have since at least 1990, according to data compiled by Bloomberg, taking advantage of weaker currencies that cheapened deals.
And going into 2017, some in the industry remain optimistic.
“Trump’s election has injected enormous confidence into the markets, and nothing is more important to M&A than confidence in the future,” said John Reiss, head of the global mergers and acquisitions practice at law firm White & Case LLP. “We remain very optimistic for 2017 dealmaking and expect it to be more active than in 2016, but less so than 2015.”
US companies especially could be big beneficiaries.
“If Trump continues to be perceived as willing and able to implement his pro-business agenda, it will increase the ability of US companies to make acquisitions around the world, and increase the attractiveness of the US to non-US acquirers,” Reiss said. “Overall, the US will be perceived as a relatively good place to do deals.”
US President Donald Trump and Chinese President Xi Jinping (習近平) were born under the sign of Gemini. Geminis are known for their intelligence, creativity, adaptability and flexibility. It is unlikely, then, that the trade conflict between the US and China would escalate into a catastrophic collision. It is more probable that both sides would seek a way to de-escalate, paving the way for a Trump-Xi summit that allows the global economy some breathing room. Practically speaking, China and the US have vulnerabilities, and a prolonged trade war would be damaging for both. In the US, the electoral system means that public opinion
In their recent op-ed “Trump Should Rein In Taiwan” in Foreign Policy magazine, Christopher Chivvis and Stephen Wertheim argued that the US should pressure President William Lai (賴清德) to “tone it down” to de-escalate tensions in the Taiwan Strait — as if Taiwan’s words are more of a threat to peace than Beijing’s actions. It is an old argument dressed up in new concern: that Washington must rein in Taipei to avoid war. However, this narrative gets it backward. Taiwan is not the problem; China is. Calls for a so-called “grand bargain” with Beijing — where the US pressures Taiwan into concessions
The term “assassin’s mace” originates from Chinese folklore, describing a concealed weapon used by a weaker hero to defeat a stronger adversary with an unexpected strike. In more general military parlance, the concept refers to an asymmetric capability that targets a critical vulnerability of an adversary. China has found its modern equivalent of the assassin’s mace with its high-altitude electromagnetic pulse (HEMP) weapons, which are nuclear warheads detonated at a high altitude, emitting intense electromagnetic radiation capable of disabling and destroying electronics. An assassin’s mace weapon possesses two essential characteristics: strategic surprise and the ability to neutralize a core dependency.
Chinese President and Chinese Communist Party (CCP) Chairman Xi Jinping (習近平) said in a politburo speech late last month that his party must protect the “bottom line” to prevent systemic threats. The tone of his address was grave, revealing deep anxieties about China’s current state of affairs. Essentially, what he worries most about is systemic threats to China’s normal development as a country. The US-China trade war has turned white hot: China’s export orders have plummeted, Chinese firms and enterprises are shutting up shop, and local debt risks are mounting daily, causing China’s economy to flag externally and hemorrhage internally. China’s
RSS